HOME >> BIOLOGY >> NEWS
Synthetic peptide targets latent papilloma virus infections

Berkeley -- While a newly marketed vaccine promises to drastically reduce human papilloma virus (HPV) infections, the major cause of cervical cancer, a new discovery by University of California, Berkeley, researchers could some day help the millions of people already infected and at constant risk of genital warts and cancer.

One study found that 75 percent of sexually active men and women under 50 have, or have had, an HPV infection, while 10,000 women annually develop cervical cancer, more than 90 percent of which is caused by HPV. Four thousand women die of cervical cancer each year.

Once infected, it's difficult to rid oneself of the virus because it hides as a latent DNA in cells of the epithelial tissue, such as skin and the lining of the vagina and cervix, and spreads as these cells divide.

The UC Berkeley team created a protein fragment, or peptide, that successfully prevents the virus from hitching a ride on a cell's chromosomes as the cell divides. If such a peptide - or more likely, a drug that mimics the action of the peptide - works in the body, it would effectively stop the virus from spreading or generating warts, which can progress to cancer.

"We're optimistic that this will work generally for many different genetic variants of human papilloma virus, though it's too early to say how many of the genotypes of this virus will respond," said Michael Botchan, professor of molecular and cell biology and a faculty affiliate of the UC Berkeley branch of the California Institute for Quantitative Biology (QB3). "The hope is to have one drug that works for all different human virus types."

"The second most preventable cancer in the world, after lung cancer, is cervical cancer, the result of high HPV infection rates in the developing world, in Asia and South America and Africa," he added. "If we can get something to stop HPV replication, it would have a big health impact."

Botchan, post-doctoral fellow Eric
'"/>

Contact: Robert Sanders
rsanders@berkeley.edu
510-643-6998
University of California - Berkeley
2-Jan-2007


Page: 1 2 3 4

Related biology news :

1. Synthetic adhesive mimics sticking powers of gecko and mussel
2. Springer to publish new journal Systems and Synthetic Biology
3. Synthetic molecule causes cancer cells to self-destruct
4. New designer lipid-like peptide with lipid nanostructures for drug delivery systems
5. New NIST reference material for peptide analysis
6. UCLA AIDS Institute researchers find a peptide that encourages HIV infection
7. Therapeutic peptide frees the protein p73 to kill tumor cells
8. Scientists identify 36 genes, 100 neuropeptides in honey bee brains
9. Defense peptide found in primates may block some human HIV transmissions
10. Patent awarded for LSUHSC-developed peptide that blocks lethal toxins of anthrax
11. Targeted drug delivery now possible with pHLIP peptide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... ... September 21, 2018 , ... VTE can ... untreated, can lead to significant morbidity and mortality. VTE affects between 300-600,000 Americans ... autopsy. Further, PE is the leading cause of preventable hospital death and maternal ...
(Date:9/12/2018)... ... September 11, 2018 , ... Tennant ... introduce the new ChemXP™ line of high performance secondary containment coatings, designed to ... to provide Tennant Coatings’ elite certified installers with the needed solutions to protect ...
(Date:9/7/2018)... ... September 06, 2018 , ... Sensors Midwest ... show Sensors Expo & Conference , announces their partnership with Fraunhofer USA ... an IoT Enabled Industrial IoT Certification Program. Taking place on October 17, 2018 ...
Breaking Biology News(10 mins):
(Date:9/13/2018)... ... September 13, 2018 , ... Asymmetrex’s director, James L. ... have gotten in medicine, if we didn’t have the means to measure the number ... His answer, “Nowhere! And that is what’s holding up progress in stem cell ...
(Date:9/12/2018)... ... 11, 2018 , ... Sterlitech Corporation, a global leader in ... from Fluid Technology Solutions (FTS H2O) to their offering of filtration products. ... triacetate (CTA) material. The highly hydrophilic nature of the CTA FO membranes favors ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... September 25th-28th is a meeting of “The industry’s preeminent event on novel drug ... discovery scientists powerful tools to study these emerging targets in a quest to ...
(Date:9/7/2018)... , ... September 06, 2018 , ... Akadeum Life Sciences ... spent his career as an executive and leader of numerous biotech companies. , ... therapy and biologics company acquired by Thompson Street Capital in St. Louis, MO. ...
Breaking Biology Technology:
Cached News: